Running a tightrope: regulatory challenges in the development of antiretrovirals. | Antiviral Res;85(1): 232-40, 2010 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Running a tightrope: regulatory challenges in the development of antiretrovirals.

Naeger, Lisa K; Struble, Kimberly A; Murray, Jeffrey S; Birnkrant, Debra B.

Affiliation

Naeger LK; Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States. lisa.naeger@fda.hhs.gov

Antiviral Res ; 85(1): 232-40, 2010 Jan.

Article in En | MEDLINE | ID: mdl-19665489

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Drug Approval / Anti-HIV Agents / Drug Discovery Limits: Humans Language: En Journal: Antiviral Res Year: 2010 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Drug Approval / Anti-HIV Agents / Drug Discovery Limits: Humans Language: En Journal: Antiviral Res Year: 2010 Document type: Article Affiliation country: Country of publication: